Abiopharma

Aura Biosciences Announces Enrollment Completion in Phase 3 CoMpass Trial of Bel-sar in Early Choroidal Melanoma

TaoWeave Expands Into Physical AI With Investment in Manako Labs and North American Commercialization Rights

Amneal to Participate in Goldman Sachs 47th Annual Global Healthcare Conference 2026

PSQ Holdings Announces Updates to Board of Directors

IMFINZI® (durvalumab) plus IMJUDO® (tremelimumab-actl) combined with lenvatinib and TACE reduced the risk of disease progression or death by 30% in embolization-eligible unresectable liver cancer in EMERALD-3 Phase III trial

AMC Entertainment Records Its Highest Domestic and Global May Attendance Since 2019

U.S. Marine Corps Expands Autonomous Fires Capability with Oshkosh Defense ROGUE-Fires Block 2 Award

Vertex Announces US FDA Acceptance of Biologics License Application for Accelerated Approval of Povetacicept in IgA Nephropathy

Q.E.P. Co., Inc. Reports Fiscal 2026 Full Year Financial Results

Senseonics Highlights Analyst Event and Oral Presentation of Eversense 365 Real-World Evidence at ADA 2026